ATRX and neoplasm: Numerous prognostic genomic features have been characterized as predictors of survival for pNENs, including mutations in DAXX/ATRX and MEN1, the expression levels of somatostatin receptors 2 and 5, elements of the tumor immune microenvironment, and enzymes involved in hormone metabolism (51, 52).